Concepedia

Robert A. Doti

RA

Statistics

Publications

5

Citations

172

H-Index

5

Active since

1998

Affiliations

Eli Lilly (United States)(Current)

Robert A. Doti is an author at Eli Lilly (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1998–2016

5

Publications

5

Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13

Lauren G. Monovich, Rubén Tommasi, Roger A. Fujimoto et al. · Journal of Medicinal Chemistry · 2009 · 58 citations · Full text

, , +13

3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists

David A. Neel, Matthew L. Brown, Peter A. Lander et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 54 citations

, , +10

Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design

Norman E. Hughes, Thomas J. Bleisch, Scott A. Jones et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 22 citations · Full text

, , +16

Carboxy-Substituted Cinnamides:  A Novel Series of Potent, Orally Active LTB<sub>4</sub> Receptor Antagonists

Paul D. Greenspan, Roger A. Fujimoto, Paul Marshall et al. · Journal of Medicinal Chemistry · 1998 · 20 citations · Full text

, , +16

Simultaneous determination of enantiomeric purity and erythro/threo relationship in chiral 1,2-aminoalcohols by NMR using (R)-(+)-t-butylphenylphosphinothioic acid

Karl Gunderson, Michael J. Shapiro, Robert A. Doti et al. · Tetrahedron Asymmetry · 1999 · 18 citations

, , +4

1–5 of 5